These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo. Guo QL; Wu MS; Chen Z Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101 [TBL] [Abstract][Full Text] [Related]
6. Selective apoptosis of natural killer-cell tumours by l-asparaginase. Ando M; Sugimoto K; Kitoh T; Sasaki M; Mukai K; Ando J; Egashira M; Schuster SM; Oshimi K Br J Haematol; 2005 Sep; 130(6):860-8. PubMed ID: 16156856 [TBL] [Abstract][Full Text] [Related]
7. Advantages in the use of L-asparaginase-albumin polymer as an antitumor agent. Poznansky MJ; Shandling M; Salkie MA; Elliott JF; Lau E Cancer Res; 1982 Mar; 42(3):1020-5. PubMed ID: 6895861 [TBL] [Abstract][Full Text] [Related]
8. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response. Riva CM; Rustum YM Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596 [TBL] [Abstract][Full Text] [Related]
9. [Results of an experimental study of the antitumor activity of 1-asparaginase from E. coli and Erw. carotovora]. Terent'eva TG; Sokolov AB; Navashin SM Antibiotiki; 1977 Jan; 22(1):78-81. PubMed ID: 320935 [TBL] [Abstract][Full Text] [Related]
10. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells. Williams RM; Germain RN; Benacerraf B J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740 [TBL] [Abstract][Full Text] [Related]
11. [L-asparaginase--first specific cytostatic]. Marquardt H Arzneimittelforschung; 1968 Nov; 18(11):1380-6. PubMed ID: 4885156 [No Abstract] [Full Text] [Related]
13. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response. Gordon WC; Prager MD Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275 [TBL] [Abstract][Full Text] [Related]
14. Anticancer properties of highly purified L-asparaginase from Withania somnifera L. against acute lymphoblastic leukemia. Oza VP; Parmar PP; Kumar S; Subramanian RB Appl Biochem Biotechnol; 2010 Mar; 160(6):1833-40. PubMed ID: 19448978 [TBL] [Abstract][Full Text] [Related]
15. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation. Jolivet J; Cole DE; Holcenberg JS; Poplack DG Cancer Res; 1985 Jan; 45(1):217-20. PubMed ID: 2578094 [TBL] [Abstract][Full Text] [Related]
16. [Physicochemical properties and antileukemic activity of crystalline L-asparaginase from Escherichia coli]. Nikolaev AIa; Kozlov EA; Sokolov NN; Kondrat'eva NA; Dobrynin IaV Vopr Med Khim; 1974 May; 20(3):272-6. PubMed ID: 4599797 [No Abstract] [Full Text] [Related]
17. Effect of l-asparaginase and asparagine deprivation on RNA metabolism in mouse leukemia L 5178Y cells in suspension culture. Nakashima T; Kuwano M; Akiyama S; Endo H Cancer Res; 1976 Oct; 36(10):3616-21. PubMed ID: 986238 [TBL] [Abstract][Full Text] [Related]
18. [Physico-chemical properties of deamidase AG from Pseudomonas fluorescens AG possessing antitumor activity]. Rakov SS; Prozorovskiĭ VN; Grebenshchikova OG; Kondrat'eva NA Vopr Med Khim; 1977; 23(4):503-8. PubMed ID: 411253 [TBL] [Abstract][Full Text] [Related]